eli lily glp-1 Lilly's KwikPen Delivers Month of Zepbound in One Device Eli Lilly Just Launched a
Description
In late April 2025, the FDA issued a key update regarding the use of compounded GLP-1 receptor agonists like semaglutide and tirzepatide
A Yale Medicine expert on restless legs syndrome discusses new treatment recommendations.
Evernorth is committed to building solutions that make health care better, finding innovative ways to surround patients with specialized clinical care and help plan sponsors manage high-costs, unstable access, and fragmented outcomes.
Weight loss pills safe for kidneys
Get the 2026 FDA update on compounded tirzepatide and how Novanex maintains COA-verified, 503A-compliant safety.
